Robert Di Silvio
2016
In 2016, Robert Di Silvio earned a total compensation of $224.5K as President at Xtant Medical Holdings.
Compensation breakdown
| Other | $224,500 |
|---|---|
| Total | $224,500 |
Di Silvio received $224.5K in other compensation, accounting for 100% of the total pay in 2016.
Rankings
In 2016, Robert Di Silvio's compensation ranked 13,242nd out of 14,075 executives tracked by ExecPay. In other words, Di Silvio earned more than 5.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,242 out of 14,075 | 6th |
Division Manufacturing | 5,173 out of 5,489 | 6th |
Major group Chemicals And Allied Products | 1,815 out of 1,895 | 4th |
Industry group Drugs | 1,475 out of 1,538 | 4th |
Industry Biological Products, Except Diagnostic Substances | 267 out of 279 | 4th |
Source: SEC filing on January 22, 2018.
Di Silvio's colleagues
We found six more compensation records of executives who worked with Robert Di Silvio at Xtant Medical Holdings in 2016.
2016
Daniel Goldberger
Xtant Medical Holdings
Chief Executive Officer
2016
Kevin O'Dare
Xtant Medical Holdings
Area Vice President-East
2016
John Gandolfo
Xtant Medical Holdings
Chief Financial Officer
2016
Carl O'Connell
Xtant Medical Holdings
Chief Executive Officer
2016
David Kirschman
Xtant Medical Holdings
Chief Scientific Officer
2016
Christopher Valois
Xtant Medical Holdings